Monogram Launches Companion Diagnostic To Pfizer’s New HIV Drug
This article was originally published in The Gray Sheet
Executive Summary
South San Francisco-based Monogram Biosciences launched its Trofile HIV diagnostic Aug. 6, timed with FDA approval of Pfizer's first-in-class HIV drug Selzentry (maraviroc) the same day